Antibiotic stewardship software for critical access hospitals, what a 25-bed hospital actually needs to buy
Most critical access hospitals do not need an enterprise surveillance platform. They need evidence for a CMS condition of participation, a way to track antibiotic use, expert help they cannot hire, and an antibiogram their prescribers trust. Here is what to buy for each, and what to skip.
9 min read
A critical access hospital needs three things from antibiotic stewardship software: evidence that it runs the program CMS requires under 42 CFR 485.640, a way to track antibiotic use, and a local or regional antibiogram its prescribers will actually use. For most 25-bed hospitals that means the EHR's own use reports, a telestewardship partner for infectious disease expertise, and a small antibiogram tool for the resistance side. It rarely means a multi-year enterprise surveillance contract.
This is written for the pharmacy director or stewardship lead at a critical access hospital who has been handed the program, has no infectious disease physician on staff, and is now getting demo invitations from vendors whose smallest customer is ten times their size. It describes public bodies and vendors only from their own published material.
What CMS actually requires of a critical access hospital
The requirement is a condition of participation, not a guideline. Under 42 CFR 485.640, finalized at 84 FR 51827 in September 2019, a critical access hospital must have an active facility-wide program for the optimization of antibiotic use through stewardship, and it must address antibiotic use issues in coordination with its QAPI program.
Paragraph (b) spells out what a surveyor will look for. The program leader must be qualified through education, training or experience in infectious diseases or antibiotic stewardship, appointed by the governing body on the recommendation of medical staff and pharmacy leadership. The program must coordinate everyone responsible for antibiotic use and resistance, including infection prevention, QAPI, medical staff, nursing and pharmacy, and it must document the evidence-based use of antibiotics in all departments and services.
Two details matter for buying decisions. First, a critical access hospital inside a multi-facility system can be covered by a unified, system-wide stewardship program, provided it still has a designated local person and the program accounts for its patient population. If your system already licenses a surveillance platform, ask to be brought under it before you buy anything. Second, the Medicare Promoting Interoperability Program has required eligible hospitals and critical access hospitals, since calendar year 2024, to attest to active engagement with the CDC NHSN Antimicrobial Use and Resistance module or claim an exclusion. That is an EHR and reporting question, and it is where your EHR vendor comes in.
The four kinds of software a critical access hospital gets pitched
The market is confusing because four different product types all get called stewardship software. They solve different parts of the problem and they are bought differently.
| Option | What it does | What it needs from you | Fit for a critical access hospital |
|---|---|---|---|
| EHR stewardship module (Epic, Oracle Health, MEDITECH) | Antibiotic use reports, worklists and alerts inside the EHR | Build time from your EHR team, or your system's build | Good if the build already exists in your system |
| Enterprise surveillance platform (Sentri7, TheraDoc, VigiLanz, BD HealthSight) | Real-time alerts, NHSN AUR submission, dashboards | HL7 interface, implementation project, negotiated contract | Rarely, unless your health system already licenses it |
| Telestewardship service | Remote infectious disease pharmacists or physicians who review patients and lead the program | A service contract and remote EHR access | The usual answer to the missing ID expertise |
| Antibiogram and resistance reporting tool (Antimicrobe, or WHONET on the desktop) | Cumulative antibiogram and resistance trends from lab data | A CSV export from the lab | Covers the resistance half of tracking and reporting |
Why an enterprise platform is usually the wrong first purchase
Sentri7, TheraDoc, VigiLanz and BD HealthSight are capable platforms, and none of them publishes a price. Each assumes an interface to your EHR and an implementation project run by your IT team. Critical access hospitals are the facilities least able to supply that. A 2024 study in Antimicrobial Stewardship and Healthcare Epidemiology followed 19 critical access hospitals across five states through a stewardship quality improvement cohort and found that difficulty obtaining data, often because of a lack of IT support, was among the most frequently reported barriers. Nine hospitals named bandwidth as a primary barrier, with one person often serving as both stewardship leader and pharmacy director.
Buying a platform does not remove that constraint. It adds a project to it. The alerting is also sized for volumes you do not have: a real-time worklist earns its keep when a team reviews dozens of patients on antibiotics every morning, not when the census is in single digits.
If your system does license one of these platforms, the comparison in Sentri7 vs TheraDoc vs VigiLanz covers what each vendor claims, and our page on TheraDoc competitors and alternatives covers the options at renewal. Inovalon sells VigiLanz Starter specifically to critical access hospitals for AUR reporting, and the VigiLanz alternatives page explains why that tier does not include the antibiogram.
Telestewardship covers the expertise, not the data
The hardest part of 485.640 for a small hospital is the qualified leader. A 2025 review in Open Forum Infectious Diseases notes that rural and critical access hospitals serve roughly 15 percent of the US population and use antibiotics at a rate and spectrum similar to large urban hospitals, while facing a national shortage of infectious disease physicians, pharmacists and infection control staff. Its proposed answer is tiered telehealth stewardship, from consultative access to experts up to full-service program leadership with daily patient review.
Telestewardship services such as MDstewardship and Access TeleCare sell exactly that, and many health systems run the same model internally, with an infectious disease pharmacist at the hub hospital covering the critical access hospitals in its network. What a remote pharmacist cannot do is invent your local resistance data. They will ask for your antibiogram in the first week, and that is where most small hospitals discover they do not have a usable one.
Why the antibiogram is the hard part in a small hospital
CLSI M39 recommends publishing a percent susceptible only for organisms with at least 30 unique first isolates in the period. A critical access hospital often clears that for Escherichia coli in urine and for little else in a single year. CDC's guidance for small and critical access hospitals acknowledges this directly: where local antibiograms are unavailable, it suggests considering regional resistance data, and notes that many critical access hospitals adapt treatment recommendations from nearby hospitals.
That is a workable fallback, but it has a known weakness. A referral hospital's isolates come from a sicker, more antibiotic-exposed population, so its percentages usually understate how susceptible your community patients are, and a guideline built on them will push prescribers toward broader agents than your own data would justify. The better move is to build your own report honestly: pool two or three years of cultures, report the isolate count under every percentage, suppress the cells that cannot carry weight, and start with urine, which is the source you actually have in volume.
Long-term care faces exactly the same small denominator, and the approaches that work there carry over. Our nursing home antibiogram page sets out the four published ways to reach a usable isolate count, and the urine antibiogram page covers the cut that changes prescribing fastest. How the pooled report is built for a 25-bed hospital, and what it costs, is on the critical access hospital antibiogram page.
Tracking antibiotic use without a surveillance platform
The use side of tracking is days of therapy per 1,000 patient days, and in most critical access hospitals it comes from the EHR, not from a separate product. Ask your EHR vendor three things: whether it produces days of therapy by agent and by month, whether it supports NHSN AUR submission for the Promoting Interoperability measure, and whether your system has already built both. If the answer to the last question is yes, you are finished with the use side.
Which AUR products CDC has validated, version by version, and what a small hospital does when its EHR is not on the list, is in NHSN AUR reporting software compared. Hospitals on TruBridge, formerly CPSI, will find the antibiogram side on CPSI EHR antibiogram software.
Keep the categories straight when vendors blur them. Point-of-prescribing checks such as interactions, contraindications and renal dose adjustment belong to a clinical decision support tool that acts when the order is written. Stewardship software looks at the pattern afterwards: which agents, for how long, against which organisms.
A realistic stack for a 25-bed hospital
Put together, the setup that satisfies 485.640 without a platform contract looks like this. It is deliberately boring, and every part of it produces something a surveyor or a QAPI committee can read.
- A named stewardship leader, local or through telestewardship, appointed by the governing body
- Days of therapy per 1,000 patient days from the EHR, reviewed monthly, and NHSN AUR submission or a documented exclusion
- A cumulative antibiogram built annually from the lab export, pooled across two or three years where needed, with isolate counts printed
- A one-page facility guideline for urinary tract infection, community-acquired pneumonia and skin infection, updated from that antibiogram
- A quarterly report on antibiotic use and resistance to prescribers, nursing and the QAPI committee
What is the best antibiotic stewardship software for a small hospital?
For a small or critical access hospital, the best antibiotic stewardship software is usually the EHR module you already have for antibiotic use, combined with a lightweight antibiogram tool for resistance data and a telestewardship partner for expertise. An enterprise surveillance platform only makes sense when your health system already licenses it and extends it to you.
Can a critical access hospital use a regional antibiogram?
Yes. CDC guidance for small and critical access hospitals suggests regional resistance data where local antibiograms are unavailable. Label it as a proxy, because referral hospital isolates usually look more resistant than your own community patients. Replace it with your own pooled multi-year report as soon as your isolate counts allow.
A critical access hospital inside a health system has a better option than a referral hospital's table: a system-wide antibiogram that pools every facility's isolates under one rule set and still shows yours on its own. How systems and health departments build one is covered in regional antibiogram software for health systems.
Do we need antibiotic surveillance software?
Only for the part your EHR does not already cover. Antibiotic surveillance software comes in three kinds: use surveillance (days of therapy, usually in the EHR), real-time pharmacy surveillance that alerts on patients (Sentri7, VigiLanz, TheraDoc), and resistance surveillance built from lab results. A 25-bed hospital typically needs only the first and the last.
Resistance surveillance is the cheapest of the three to add, because it runs on the susceptibility export the lab already produces and needs no interface to the EHR.
What that looks like in practice, including MDRO counts and quarterly trends, is on the antimicrobial resistance surveillance software page.
Where Antimicrobe fits, and where it does not
Antimicrobe covers one row of the table above: the antibiogram. You export finalized susceptibility results from the lab as a CSV, and the builder de-duplicates to the first isolate per patient, suppresses cells under the threshold you set, lets you pool multiple years, and ranks empiric options by local percent susceptible, with every rule printed on the report. The file is parsed in your browser and never uploaded.
It does not fire alerts, submit AUR data to NHSN, or connect to your EHR, and it does not replace a stewardship leader. Plans are published on the pricing page, and you can run the builder on the sample dataset or on your own export today.
If you are setting up the program itself, the antibiotic stewardship program page covers the reporting side, the antimicrobial stewardship software features page lists every report, and published pricing shows what each plan includes.
Related on this site: the small-denominator problem in long-term care, TheraDoc competitors and alternatives, running the stewardship program, the cumulative hospital antibiogram.